Date: 30.1.2014
GM purple tomatoes developed by John Innes Centre scientists in the UK are being harvested in Ontario, Canada, for future research and to attract interest from private investors.
The 5000 square-foot glasshouse will yield enough tomatoes to produce 2000 litres of purple tomato juice. It will be used to generate new research and industry collaborations and to start the process of seeking the regulatory authorization needed to bring a commercial juice to market.
"We want to explore a way for consumers to benefit from our discoveries, as we are finding there is a demand for the added health benefits," says JIC's Professor Cathie Martin.
The colour of the tomatoes is derived from high levels of anthocyanins, compounds normally found in blueberries, blackberries and other deeply coloured berries. The purple tomatoes have been shown to have anti-inflammatory effects compared to regular ones and to slow the progression of soft-tissue carcinoma in cancer-prone mice. They also have double the shelf life.
"The most amazing thing is the potential to supply an expensive compound from nature more economically to large markets for food, livestock feed, cosmetics, food colourings and even pharmaceuticals," says Paul Carver, CEO of New Energy Farms where the tomatoes are being grown under glass.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Science Daily - Science Magazine
Massachusetts institute of technology - University
Biorefining process could make grass digestible for pigs, chickens, and fish
Phage cocktail shows promise against drug-resistant bacteria